Contrasting ability of antiestrogens to inhibit MCF-7 growth stimulated by estradiol or epidermal growth factor
- 1 January 1989
- journal article
- research article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 25 (1) , 57-63
- https://doi.org/10.1016/0277-5379(89)90051-5
Abstract
No abstract availableThis publication has 32 references indexed in Scilit:
- Antiestrogens inhibit the mitogenic effect of growth factors on breast cancer cells in the total absence of estrogensBiochemical and Biophysical Research Communications, 1987
- Epidermal growth factor partially reverses the inhibitory effects of antiestrogens on T 47D human breast cancer cell growthBiochemical and Biophysical Research Communications, 1987
- The biology of platelet-derived growth factorCell, 1986
- Autocrine and paracrine growth regulation of human breast cancerBreast Cancer Research and Treatment, 1986
- Human breast cancer cells synthesize and secrete an EGF-like immunoreactive factor in cultureBiochemical and Biophysical Research Communications, 1986
- Autocrine and paracrine growth regulation of human breast cancerJournal of Steroid Biochemistry, 1986
- Long-term tamoxifen adjuvant therapy in node-positive breast cancer: A metabolic and pilot clinical studyBreast Cancer Research and Treatment, 1984
- Tamoxifen stimulation of human breast cancer cell proliferation in vitro: a possible model for tamoxifen tumour flareEuropean Journal of Cancer and Clinical Oncology, 1984
- Tamoxifen induces accumulation of MCF 7 human mammary carcinoma cells in the G0/G1 phase of the cell cycleEuropean Journal of Cancer and Clinical Oncology, 1983
- Autocrine Secretion and Malignant Transformation of CellsNew England Journal of Medicine, 1980